Login / Signup

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.

Tomokazu TamuraJumpei ItoKeiya UriuJiri ZahradnikIzumi KidaYuki AnrakuHesham NasserMaya ShofaYoshitaka OdaSpyros LytrasNaganori NaoYukari ItakuraSayaka DeguchiRigel SuzukiLei WangMst Monira BegumShunsuke KitaHisano YajimaJiei SasakiKaori Sasaki-TabataRyo ShimizuMasumi TsudaYusuke KosugiShigeru FujitaLin PanDaniel SauterKumiko YoshimatsuSaori SuzukiHiroyuki AsakuraMami NagashimaKenji SadamasuKazuhisa YoshimuraYuki YamamotoTetsuharu NagamotoGideon SchreiberKatsumi Maenakanull nullTakao HashiguchiTerumasa IkedaTakasuke FukuharaAkatsuki SaitoShinya TanakaKeita MatsunoKazuo TakayamaKei Sato
Published in: Nature communications (2023)
In late 2022, SARS-CoV-2 Omicron subvariants have become highly diversified, and XBB is spreading rapidly around the world. Our phylogenetic analyses suggested that XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1 (a progeny of BA.2.75), during the summer of 2022. XBB.1 is the variant most profoundly resistant to BA.2/5 breakthrough infection sera to date and is more fusogenic than BA.2.75. The recombination breakpoint is located in the receptor-binding domain of spike, and each region of the recombinant spike confers immune evasion and increases fusogenicity. We further provide the structural basis for the interaction between XBB.1 spike and human ACE2. Finally, the intrinsic pathogenicity of XBB.1 in male hamsters is comparable to or even lower than that of BA.2.75. Our multiscale investigation provides evidence suggesting that XBB is the first observed SARS-CoV-2 variant to increase its fitness through recombination rather than substitutions.
Keyphrases
  • sars cov
  • dna repair
  • dna damage
  • respiratory syndrome coronavirus
  • structural basis
  • endothelial cells
  • hiv infected
  • angiotensin ii
  • pseudomonas aeruginosa
  • transcription factor
  • antiretroviral therapy
  • candida albicans